What's new in IDIS:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Continuing Education Articles

 • Priority Clinical Practice Guidelines

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - September 2012

NEW DRUG TERM
BMS-833923
E-7974
GS-6624
IPRAGLIFLOZIN
IXAZOMIB
LDE-225
LX-4211
PD-0299685
PF-0444913
SARIDEGIB
TIVOZANIB
TRIPTOLIDE

CODE
10121031
10121037
10121035
68200455
10121030
10121032
68200454
92000383
10121033
10121034
10121036
92000382



DRUG NAME/CODE CHANGES

OLD TERM & CODE
CAL-101 10120964
COMBRETASTATIN A-4 10120213
E-7080 14000514
M-118 20120474
MICROPLASMIN 44000030
PTC-124 92000276

NEW TERM & CODE
GS-1101 10120964
FOSBRETABULIN 10120213
LENVATINIB 14000514
ADOMIPARIN 20120474
OCRIPLASMIN 20400027
ATALUREN 92000276


FDA APPROVAL PACKAGES

Article Numbers 681865-681878: Sodium Picosulfate, Magnesium Oxide, and Citric Acid; Prepopik, FDA Approval Package for NDA 202535. FDA Approval Package 2012.

Article Numbers 681850-681864: Lorcaserin Hydrochloride, Belviq, FDA Approval Package for NDA 22529. FDA Approval Package 2012.

Article Numbers 681835-681849: Pertuzumab, Perjeta , FDA Approval Package for BLA 125409. FDA Approval Package 2012.


ADVISORY COMMITTEE MEETINGS

Article Numbers 682285-682291: Oncologic Drugs Advisory Committee Meeting, July 24, 2012. FDA Advisory Committee 2012.


CONTINUING EDUCATION ARTICLES

Article Number 682862: Anonymous. Drugs for Chronic Heart Failure (0.2 CEU). Treat Guidel Med Lett 2012, 10:69-72.

Article Number 682390: Anonymous. Cost of Drugs for Actute Cystitis. Med Lett Drugs Ther 2012, 54:67-68.

Article Number 682389: Anonymous. Ezogabine (Potiga) for Epilepsy. Med Lett Drugs Ther 2012, 54:65-67.

Article Number 682319: Anonymous. In Brief: Truvada for HIV Prevention (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682317-682319]. Med Lett Drugs Ther 2012, 54:63-64.

Article Number 682318: Anonymous. Tablet Splitting (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682317-682319]. Med Lett Drugs Ther 2012, 54:63.

Article Number 682317: Anonymous. Ivermectin (Sklice) Topical Lotion for Head Lice (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682317-682319]. Med Lett Drugs Ther 2012, 54:61-63.

Article Number 682315: Anonymous. A New Scorpion Antivenom (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682314 and 682315]. Med Lett Drugs Ther 2012, 54:51-52.

Article Number 682314: Anonymous. Bisphosphonates--Duration of Use Revisited (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682314 and 682315]. Med Lett Drugs Ther 2012, 54:49.

Article Number 682313: Anonymous. Pertuzumab (Perjeta) for HER2-Positive Metastatic Breast Cancer (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 682311-682313]. Med Lett Drugs Ther 2012, 54:59-60.

Article Number 682311: Anonymous. Drugs for Urinary Tract Infections (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 682311-682313]. Med Lett Drugs Ther 2012, 54:57-58.

Article Number 682309: Anonymous. Tafluprost (Zioptan)--A New Topical Prostaglandin for Glaucoma (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682308 and 682309]. Med Lett Drugs Ther 2012, 54:31-32.

Article Number 682308: Anonymous. Ivacaftor (Kalydeco) for Cystic Fibrosis (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682308 and 682309]. Med Lett Drugs Ther 2012, 54:29-30.

Article Number 682307: Anonymous. Ruxolitinib (Jakafi) for Myelofibrosis (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 682305-682307]. Med Lett Drugs Ther 2012, 54:27-28.

Article Number 682306: Anonymous. Bupivacaine Liposome Injection (Exparel) for Postsurgical Pain (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 682305-682307]. Med Lett Drugs Ther 2012, 54:26-27.

Article Number 682305: Anonymous. Low-Dose Sublingual Zolpidem (Intermezzo) for Insomnia Due to Middle-Of-The-Night Awakening (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 682305-682307]. Med Lett Drugs Ther 2012, 54:25-26.

Article Number 682303: Anonymous. Nitroglycerin Ointment (Rectiv) for Anal Fissure (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682301-682303]. Med Lett Drugs Ther 2012, 54:23-24.

Article Number 682302: Anonymous. Extended-Release Exenatide (Bydureon) for Type 2 Diabetes (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682301-682303]. Med Lett Drugs Ther 2012, 54:21-23.

Article Number 682301: Anonymous. Statin Label Changes (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 682301-682303]. Med Lett Drugs Ther 2012, 54:21.

Article Number 682177: Cada D J, Levien T L, Baker D E. Exenatide Extended-Release Injection (0.15 CEU). Hosp Pharm 2012, 47:633-644.

Article Number 681804: Anonymous. Antifungal Drugs (0.2 CEU). Treat Guidel Med Lett 2012, 10:61-68.

Article Number 681599: Cada D J, Demaris K, Levien T L, Baker D E. Ivacaftor (0.15 CEU). Hosp Pharm 2012, 47:544-549.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 682298: Anonymous. Full Guideline. Lower Limb Peripheral Arterial Disease: Diagnosis and Management. NICE Clinical Guideline No. 147 (Ref Art 682298-682300). NICE Clin Guidel 2012.

Article Number 682295: Anonymous. Full Guideline. Osteoporosis: Assessing the Risk of Fragility Fracture. NICE Clinical Guideline No. 146 (Ref Art 682295-682297). NICE Clin Guidel 2012.

Article Number 681882: Anonymous. Full Guideline. Spasticity in Children and Young People with Non-Progressive Brain Disorders. NICE Clinical Guideline No. 145 (Ref Art 681882-681884). NICE Clin Guidel 2012.

Article Number 681658: Armstrong M J, Miyasaki J M. Evidence-Based Guideline: Pharmacologic Treatment of Chorea in Huntington Disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012, 79:597-603.


College of Pharmacy